vTv Therapeutics Inc. 8-K

What Happened

• vTv Therapeutics Inc. filed a Form 8-K on March 10, 2026 (Item 2.02) to announce its results of operations and financial condition for the fiscal year ended December 31, 2025. The company issued a press release dated March 10, 2026 reporting those results; that press release is attached as Exhibit 99.1 to the 8-K.
• The Form 8-K was signed by Paul J. Sekhri, President and Chief Executive Officer of vTv Therapeutics.

Key Details

• Event type: Item 2.02 — Results of Operations and Financial Condition (full-year 2025 results announced).
• Press release date and filing date: March 10, 2026; the press release is attached as Exhibit 99.1 to the 8-K.
• Fiscal period covered: year ended December 31, 2025.
• The company states the information in the press release is furnished (not "filed") under the Exchange Act and is not incorporated by reference into other filings except where expressly stated.

Why It Matters

• This 8-K signals that vTv has released its full-year 2025 earnings and related financial information; investors should read the attached press release for the company’s reported revenue, net income/loss, cash position, and any commentary on operations or guidance.
• Because the release is furnished rather than filed, auditors’ or SEC-incorporated disclosures may follow in the company’s Form 10-K; investors should compare the press release figures to analyst expectations and await the 10-K for audited, detailed financial statements.